GENE ONLINE|News &
Opinion
Blog

Progression Free Survival
Breakthrough in Breast Cancer for 2.3 Million Women: evERA Trial Delivers 70% ER Positive Insight with Giredestrant Combo
2025-09-25
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
The ups and downs of Chi-Med’s Fruquintinib
2018-11-28
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
LATEST
LA28 Releases New Hospitality Packages for Equestrian, Golf, and Beach Volleyball Events
2026-07-14
Johns Hopkins Technology Ventures Details Commercialization Strategies at BIO International Convention
2026-07-14
Pittsburgh Steelers Select Priority Technology Holdings to Manage Ticketing Payments and Treasury Operations
2026-07-14
Suja Organic Partners With Ashley Iaconetti for Summer of Loves Campaign
2026-07-14
Tempus Realty Partners Acquires $42 Million in Arkansas Commercial Real Estate
2026-07-14
Tempo Launches Cook Never Club to Reduce Meal Preparation Time for Millennials and Gen Z
2026-07-14
Danielle Fishel and Lance Bass Named QVC Co-Chief Cheer Officers for Christmas in July Event
2026-07-14
Scroll to Top